Introgen Therapeutics, Inc. to Host Conference Call with Clinical Investigators to Discuss Phase III Data and ADVEXIN Registration Activities

AUSTIN, Texas--(BUSINESS WIRE)--Introgen Therapeutics, Inc. (NASDAQ:INGN) announced today that it will host a conference call with management and invited clinical experts on Thursday, July 10, 2008 at 3:30 p.m. ET.